In clinical settings, low levels of adropin have been found in individuals with arterial hypertension, obesity, T2DM, metabolic syndrome, coronary artery disease, atherosclerosis, stroke, acute coronary syndrome, chronic kidney disease, and all phenotypes of symptomatic HF [21,22,23,24,25,26,27]. The gene discussed is ENHO; the disease is coronary artery disorder.